PAM
WHWK

Panagora Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

Panagora Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,975
Closed -$44K – 2946
2020
Q4 		$44K Buy
+2,975
New +$63.6K ﹤0.01% 2070
2020
Q2 		– Sell
-99
Closed -$1K – 2662
2020
Q1 		$1K Hold
99
– – ﹤0.01% 2457
2019
Q4 		$1K Sell
99
-389
-80% -$3.24K ﹤0.01% 2417
2019
Q3 		$5K Sell
488
-3,784
-89% -$41.9K ﹤0.01% 2295
2019
Q2 		$58K Buy
4,272
+3,401
+390% +$51.6K ﹤0.01% 2065
2019
Q1 		$12K Buy
871
+417
+92% +$17.9K ﹤0.01% 2344
2018
Q4 		$12K Buy
+454
New +$14.5K ﹤0.01% 2302

Other funds holding WHWK

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return

Panagora Asset Management's WHWK Position: Q1 2021 in Review

Panagora Asset Management sold out of Whitehawk Therapeutics (WHWK) in Q1 2021, closing a stake of 2,975 shares — an estimated $44K sold.

Panagora Asset Management first reported a position in WHWK in Q4 2018 and held it in 7 quarters. The position peaked at $58K in Q2 2019. 42 funds tracked by Wall St. Rank hold WHWK as of Q1 2021.

  • Panagora Asset Management reported no remaining Whitehawk Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 2,975 Whitehawk Therapeutics shares in Q1 2021, an estimated $44K.
  • Panagora Asset Management first reported a position in Whitehawk Therapeutics in Q4 2018 and held it in 7 quarters.
  • Panagora Asset Management's Whitehawk Therapeutics position peaked at $58K in Q2 2019.
  • 42 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.